C121H146N20O13S4 — CID 159486536
(2S)-N-[(1S)-1-(1-acetylpiperidin-4-yl)-2-oxo-2-[(2S)-2-(4-phenyl-[1,3]thiazolo[4,5-c]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2S)-2-(7-phenyl-[1,3]thiazolo[5,4-b]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(2-hydroxyethylamino)propanamide;(2R)-2-(2-hydroxyethylamino)-N-[(1S)-2-oxo-1-phenyl-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2S)-2-(methylamino)-N-[(1S)-2-oxo-1-[1-[(2R)-oxolane-2-carbonyl]piperidin-4-yl]-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide (PubChem CID 159486536) has the molecular formula C121H146N20O13S4 and a molecular weight of 2216.89 g/mol. Its IUPAC name is (2S)-N-[(1S)-1-(1-acetylpiperidin-4-yl)-2-oxo-2-[(2S)-2-(4-phenyl-[1,3]thiazolo[4,5-c]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2S)-2-(7-phenyl-[1,3]thiazolo[5,4-b]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(2-hydroxyethylamino)propanamide;(2R)-2-(2-hydroxyethylamino)-N-[(1S)-2-oxo-1-phenyl-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2S)-2-(methylamino)-N-[(1S)-2-oxo-1-[1-[(2R)-oxolane-2-carbonyl]piperidin-4-yl]-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide.
| Compound Name | (2S)-N-[(1S)-1-(1-acetylpiperidin-4-yl)-2-oxo-2-[(2S)-2-(4-phenyl-[1,3]thiazolo[4,5-c]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2S)-2-(7-phenyl-[1,3]thiazolo[5,4-b]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(2-hydroxyethylamino)propanamide;(2R)-2-(2-hydroxyethylamino)-N-[(1S)-2-oxo-1-phenyl-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2S)-2-(methylamino)-N-[(1S)-2-oxo-1-[1-[(2R)-oxolane-2-carbonyl]piperidin-4-yl]-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide |
|---|---|
| PubChem CID | 159486536 |
| Molecular Formula | C121H146N20O13S4 |
| Molecular Weight | 2216.89 g/mol |
| Exact Mass | 2215.03 |
| IUPAC Name | (2S)-N-[(1S)-1-(1-acetylpiperidin-4-yl)-2-oxo-2-[(2S)-2-(4-phenyl-[1,3]thiazolo[4,5-c]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-N-[(1S)-1-cyclohexyl-2-oxo-2-[(2S)-2-(7-phenyl-[1,3]thiazolo[5,4-b]pyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(2-hydroxyethylamino)propanamide;(2R)-2-(2-hydroxyethylamino)-N-[(1S)-2-oxo-1-phenyl-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2S)-2-(methylamino)-N-[(1S)-2-oxo-1-[1-[(2R)-oxolane-2-carbonyl]piperidin-4-yl]-2-[(2S)-2-(4-phenyl-1,3-benzothiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide |
| SMILES | CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(-c3ccccc3)cccc2s1)C1CCN(C(=O)[C@H]2CCCO2)CC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(-c3ccccc3)nccc2s1)C1CCN(C(C)=O)CC1.C[C@@H](NCCO)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(-c3ccccc3)cccc2s1)c1ccccc1.C[C@H](NCCO)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(-c3ccccc3)ccnc2s1)C1CCCCC1 |
| InChI | InChI=1S/C33H41N5O4S.C30H32N4O3S.C29H36N6O3S.C29H37N5O3S/c1-21(34-2)30(39)35-28(23-15-18-37(19-16-23)32(40)26-13-8-20-42-26)33(41)38-17-7-12-25(38)31-36-29-24(11-6-14-27(29)43-31)22-9-4-3-5-10-22;1-20(31-17-19-35)28(36)32-26(22-12-6-3-7-13-22)30(37)34-18-9-15-24(34)29-33-27-23(14-8-16-25(27)38-29)21-10-4-2-5-11-21;1-18(30-3)27(37)32-25(21-12-16-34(17-13-21)19(2)36)29(38)35-15-7-10-22(35)28-33-26-23(39-28)11-14-31-24(26)20-8-5-4-6-9-20;1-19(30-16-18-35)26(36)32-24(21-11-6-3-7-12-21)29(37)34-17-8-13-23(34)27-33-25-22(14-15-31-28(25)38-27)20-9-4-2-5-10-20/h3-6,9-11,14,21,23,25-26,28,34H,7-8,12-13,15-20H2,1-2H3,(H,35,39);2-8,10-14,16,20,24,26,31,35H,9,15,17-19H2,1H3,(H,32,36);4-6,8-9,11,14,18,21-22,25,30H,7,10,12-13,15-17H2,1-3H3,(H,32,37);2,4-5,9-10,14-15,19,21,23-24,30,35H,3,6-8,11-13,16-18H2,1H3,(H,32,36)/t21-,25-,26+,28-;20-,24+,26+;18-,22-,25-;19-,23-,24-/m0100/s1 |
| InChIKey | LXQQTLJIJHUESL-GNMKLHIYSA-N |
| XLogP | 16.02 |
| TPSA | 413.41 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 158 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2216.89 |
| LogP ≤ 5 | 16.02 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 27 |